US20050053559A1 - Carotenoid composition and method for protecting skin - Google Patents

Carotenoid composition and method for protecting skin Download PDF

Info

Publication number
US20050053559A1
US20050053559A1 US10/495,514 US49551404A US2005053559A1 US 20050053559 A1 US20050053559 A1 US 20050053559A1 US 49551404 A US49551404 A US 49551404A US 2005053559 A1 US2005053559 A1 US 2005053559A1
Authority
US
United States
Prior art keywords
composition
phytofluene
phytoene
carotenoid
lycopene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/495,514
Inventor
Morris Zelkha
Zohar Nir
Tanya Sedlov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lycored Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Assigned to LYCORED NATURAL PRODUCTS INDUSTRIES LTD. reassignment LYCORED NATURAL PRODUCTS INDUSTRIES LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NIR, ZOHAR, SEDLOV, TANYA, ZELKHA, MORRIS
Publication of US20050053559A1 publication Critical patent/US20050053559A1/en
Priority to US12/406,762 priority Critical patent/US10420715B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to the field of protection from sun radiation, particularly to methods and compositions effective in protecting skin.
  • a further purpose of the present invention is to provide a carotenoid composition effective in protecting the skin against the damages of uv radiation and which does present potential health risks.
  • the present invention provides a method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among a group consisting of phytoene and phytofluene.
  • said composition may further contain vitamin E.
  • composition comprising of 6% to 25% lycopene of a natural source and more than 0.3% of one or more carotenoid selected from among a group consisting of phytoene and phytofluene.
  • said composition may contain 1% to 4% vitamin E.
  • a carotenoid composition containing lycopene from a natural source and one or more carotenoid selected from among a group consisting of phytoene and phytofluene as a protective agent against uv light-induced damage to skin.
  • said composition may further contain vitamin E.
  • the present invention further provides administration forms for the presently claimed composition, wherein said administration form may be a food-stuff, beverage or pharmaceutically acceptable dosage form.
  • FIG. 1 Comparison of protection of various carotenoid compositions against erythema (see Example 2 for clarifications of terms appearing in graph)
  • lycopene of natural sources and “natural lycopene” are synonymous throughout the application and refer to lycopene from vegetables, fruits, plant matter, fungus and fungal sources, and natural bio-mass.
  • carotenoid compositions which contain natural lycopene and one or more carotenoid selected from among a group consisting of phytoene and phytofluene, are effective in protecting skin against damages caused by uv radiation from the sun, wherein said damages are erythema and sunburn.
  • natural lycopene is significantly more effective in protecting skin against uv radiation damages than synthetic lycopene.
  • a further surprising finding according to the present invention is that the addition of phytoene and/or phytofluene to the natural lycopene composition improves the effectiveness of the composition in protecting skin against uv radiation damage.
  • 1 mg to 10 mg of a composition comprising 6% to 15% of natural lycopene and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene are administered to a subject.
  • a composition comprising 6% of natural lycopene, 0.5% phytoene and 0.5% phytofluene are administered.
  • compositions may contain 1.5% to 2.5% of vitamin E. preferably, said composition containing about 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
  • compositions employed comprise natural lycopene and one or more additional carotenoid selected from among phytoene and phytofluene wherein the ratio between the lycopene and additional carotenoids is in the range of 20:1 to 5:1, preferably 8:1 to 5:1.
  • the indicated dosages refer to a healthy adult in the weight range of 50 Kg to 70 Kg and thus may vary according to body size. However, preferably, the dosage is adjusted so that the carotenoid serum level of the subject reaches a level within the range of 0.3 to 1.2 ⁇ M (micromole/liter), wherein serum levels of lycopene are 0.2 to 0.6 ⁇ M, phytoene 0.08 to 0.2 ⁇ M and phytofluene 0.08 to 0.4 ⁇ M.
  • Dosages of total carotenoids may be daily in single or multiple doses, of about 2 to 15 mg/day, preferably 5 mg/day.
  • compositions are administered by means known in the art, which will achieve the desired carotenoid serum levels.
  • Oral administration is preferred.
  • the oral administration can be in the form of a capsule, gel-cap, pellet, soft gel capsule or tablet which contain the carotenoid compositions.
  • Said oral dosage forms may contain pharmaceutically acceptable excipients, additives, carriers and stabilizers. Particularly important additives are of the type which improve bioavailability of the carotenoids, e.g. oils and surfactants.
  • Said oral dosage forms are prepared according to conventional methods known from the art.
  • a preferred means of oral administration is via foodstuff and beverages.
  • the carotenoid composition is added to foodstuff or beverages.
  • the amount of carotenoid composition in the foodstuff and beverage is adjusted to meet the above-mentioned dosages.
  • administration of the composition is preferably started before exposure to uv radiation. Preferably, 7 to 30 days before exposure, and administration is continued during exposure.
  • a novel carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among a group consisting of phytoene and phytofluene.
  • the composition comprises 6% of natural lycopene, 0.5% phytoene and 0.5% phytofluene.
  • the composition may further comprise of 1.5% to 2.5% vitamin E.
  • the composition contains 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
  • compositions of the present invention comprise natural lycopene and one or more additional carotenoid selected from among a group consisting of phytoene and phytofluene wherein the ratio between the lycopene and additional carotenoid is in the range of 20:1 to 5:1, preferably 8:1 to 5:1.
  • the composition may further contain vitamin E wherein the ratio between the lycopene and the vitamin E is in the range of 10:1 to 2:1, preferably 8:1 to 3:1.
  • a particular embodiment of the present invention relates to solid and liquid oral dosage forms selected from among a group comprising of a capsule, gel-cap, pellet, soft gel capsule, tablet, or other liquid or solid oral dosage forms known in the art, which comprises a carotenoid composition which contains 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more additional carotenoid selected from among phytoene and/or phytofluene.
  • Said oral dosage form may further comprise 1.5 mg to 8 mg of vitamin E.
  • said oral dosage form comprises 5 mg of natural lycopene, 0.5 mg phytoene, 0.45 mg phytofluene and 1.8 mg of vitamin E.
  • Said dosage form may further contain a pharmaceutically acceptable adjuvant, excepient, carrier, filler, stabilizer or additive.
  • the present invention further relates to foodstuff or beverages which contains a carotenoid composition as described herein.
  • the foodstuff or beverage contain 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among a group consisting of phytoene and phytofluene.
  • Said food-stuff or beverage may further contain 1.5 mg to 8 mg of vitamin E.
  • said food-stuff or beverage comprises 4.1 mg of natural lycopene, 2.2 mg phytoene, 1.6 mg phytofluene and 3.8 mg of vitamin E.
  • the lycopene used throughout the Examples is natural lycopene by LycoRed®.
  • each capsule contains:
  • soft gel capsules which are prepared according to standard procedures known to the skilled artisan.
  • each soft drink bottle contains
  • the carotenoid fraction is a tomato extract containing natural lycopene, phytoene, phytofluene and tocopherols.
  • the carotenoid fraction is a tomato extract similar to Lyc-O-Mato® which is further enriched with phytoene, phytofluene and tocopherols.
  • the carotenoid fraction contains synthetic lycopene and tocopherols.
  • the minimal erythema dose (MED), which is the minimal dose of uv radiation which produces a minimal erythema (reddening of the skin) after 24 hours was determined by exposing different small areas of skin to increasing doses of uv radiation.
  • the testing of the effectiveness of the carotenoid supplementation was tested by exposing the subjects to 1.25 of the individual MED at 0, 4 and 12 weeks from the beginning of lycopene supplementation.
  • the effect of the radiation on the reddening and pigmentation of the skin was measured by a Minolta chronometer.
  • the “a” and “b” value of the chronometer correlate to the reddening and pigmentation of the skin, respectively.
  • the erythema (reddening) was determined 24 hours after radiation of uv radiation, by subtracting the value of “a” before radiation from the value of “a” 24 hours after radiation. The value obtained is denoted by “ ⁇ a”. Larger values of ⁇ a correlate with increased erythema of the skin.
  • FIG. 1 clearly demonstrates the improved protective effect against uv induced erythema, Lyc-O-Mato and Lyc-O-Guard have over synthetic lycopene.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)

Abstract

A method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof.

Description

    FIELD OF THE INVENTION
  • The present invention relates to the field of protection from sun radiation, particularly to methods and compositions effective in protecting skin.
  • BACKGROUND OF THE INVENTION
  • It is well established that prolonged exposure to sun has damaging effects on the skin. Particularly, the uv radiation from the sun is known to cause erythema of the skin, sunburn and skin cancer. Protection of the skin from uv radiation can be achieved by protective attire as well as by protection in the form of topical compositions of various protective ingredients. A particular group of protective compositions are intended for oral administration. Oral compositions contain active ingredients which are delivered to the skin via an internal transport mechanism and thus protect the skin from uv radiation damage. A particular group of active ingredients which are suitable for use with said oral compositions are carotenoids. U.S. Pat. No. 3,920,834 describes the use of a mixture of carotenoids wherein cathaxanthin is the primary carotenoid in the composition. However, the use of cathaxanthin is known to be limited due to adverse effects it may have on pigmentation. U.S. Pat. No. 5,290,605 describes food-stuff and beverages intended for providing protection to the skin against uv sun radiation. Said foodstuff and beverages comprising carotenoids as well as ascorbic acid, tocopherols, coenzyme Q10 and reduced glutathione. U.S. Pat. No. 6,110,478 further describes a composition for protecting skin against uv radiation and the harmful effects thereof, wherein the composition contains a pro-vitamin A carotenoid and lycopene. The use of such a composition is limited by the negative effect pro-vitamin A carotenoids may have on the subject's health at certain dosage levels. An excess of vitamin A, which is produced in the body from pro-vitamin A carotenoids, was found to have adverse effects on health. Stahl et al (“Dietary Tomato Paste Protects against Ultraviolet Light-induced Erythema in Humans”, Biochemical and Molecular Action of Nutrients, Research Communication, (2001) 1449-1451) have shown the protective effect of tomato paste which is known to contain inter alia lycopene, β-carotene and tocopherol, against uv light-induced erythema However, Stahl has reported a problem in achieving desired carotenoid serum levels, suggesting poor bioavailability.
  • Accordingly, there is a long felt need to develop a composition for protecting skin against uv radiation which is suitable for oral administration and is safe at a wide range of dosages.
  • It is therefore a purpose of the present invention to provide a method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun.
  • A further purpose of the present invention is to provide a carotenoid composition effective in protecting the skin against the damages of uv radiation and which does present potential health risks.
  • It is yet another purpose of the present invention to provide a method and composition that overcome the disadvantages of the known art.
  • Other objectives of the invention will become apparent as the description proceeds.
  • SUMMARY OF THE INVENTION
  • The present invention provides a method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Optionally, said composition may further contain vitamin E.
  • Further provided by the present invention is a composition comprising of 6% to 25% lycopene of a natural source and more than 0.3% of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Optionally, said composition may contain 1% to 4% vitamin E.
  • Further provided by the present invention is the use of a carotenoid composition containing lycopene from a natural source and one or more carotenoid selected from among a group consisting of phytoene and phytofluene as a protective agent against uv light-induced damage to skin. Optionally, said composition may further contain vitamin E.
  • The present invention further provides administration forms for the presently claimed composition, wherein said administration form may be a food-stuff, beverage or pharmaceutically acceptable dosage form.
  • DESCRIPTION OF THE DRAWINGS
  • FIG. 1—Comparison of protection of various carotenoid compositions against erythema (see Example 2 for clarifications of terms appearing in graph)
  • DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT OF THE INVENTION
  • The following description is illustrative of embodiments of the invention. The following description is not to be construed as limiting, it being understood that the skilled person may carry out many obvious variations to the invention.
  • Throughout the description, percentages of components are by weight, unless specifically noted differently. The terms “lycopene of natural sources” and “natural lycopene” are synonymous throughout the application and refer to lycopene from vegetables, fruits, plant matter, fungus and fungal sources, and natural bio-mass.
  • It has surprisingly been found that carotenoid compositions which contain natural lycopene and one or more carotenoid selected from among a group consisting of phytoene and phytofluene, are effective in protecting skin against damages caused by uv radiation from the sun, wherein said damages are erythema and sunburn. Furthermore, unexpectedly, it has been found in the present invention that natural lycopene is significantly more effective in protecting skin against uv radiation damages than synthetic lycopene. A further surprising finding according to the present invention, is that the addition of phytoene and/or phytofluene to the natural lycopene composition improves the effectiveness of the composition in protecting skin against uv radiation damage.
  • According to an embodiment of the method of the present invention, 1 mg to 10 mg of a composition comprising 6% to 15% of natural lycopene and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene are administered to a subject. Preferably, about 5 mg of a composition comprising 6% of natural lycopene, 0.5% phytoene and 0.5% phytofluene are administered.
  • In yet a further embodiment of the present method the aforementioned compositions may contain 1.5% to 2.5% of vitamin E. preferably, said composition containing about 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
  • According to a particular embodiment of the invention, the compositions employed comprise natural lycopene and one or more additional carotenoid selected from among phytoene and phytofluene wherein the ratio between the lycopene and additional carotenoids is in the range of 20:1 to 5:1, preferably 8:1 to 5:1.
  • The indicated dosages refer to a healthy adult in the weight range of 50 Kg to 70 Kg and thus may vary according to body size. However, preferably, the dosage is adjusted so that the carotenoid serum level of the subject reaches a level within the range of 0.3 to 1.2 μM (micromole/liter), wherein serum levels of lycopene are 0.2 to 0.6 μM, phytoene 0.08 to 0.2 μM and phytofluene 0.08 to 0.4 μM. Dosages of total carotenoids may be daily in single or multiple doses, of about 2 to 15 mg/day, preferably 5 mg/day.
  • The compositions are administered by means known in the art, which will achieve the desired carotenoid serum levels. Oral administration is preferred. The oral administration can be in the form of a capsule, gel-cap, pellet, soft gel capsule or tablet which contain the carotenoid compositions. Said oral dosage forms may contain pharmaceutically acceptable excipients, additives, carriers and stabilizers. Particularly important additives are of the type which improve bioavailability of the carotenoids, e.g. oils and surfactants.
  • Said oral dosage forms are prepared according to conventional methods known from the art. A preferred means of oral administration is via foodstuff and beverages. Thus, the carotenoid composition is added to foodstuff or beverages. The amount of carotenoid composition in the foodstuff and beverage is adjusted to meet the above-mentioned dosages.
  • According to a particular embodiment of the present method, administration of the composition is preferably started before exposure to uv radiation. Preferably, 7 to 30 days before exposure, and administration is continued during exposure.
  • According to a further aspect of the present invention there is provided a novel carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Preferably, the composition comprises 6% of natural lycopene, 0.5% phytoene and 0.5% phytofluene.
  • According to yet a further embodiment the composition may further comprise of 1.5% to 2.5% vitamin E. Preferably the composition contains 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
  • The compositions of the present invention comprise natural lycopene and one or more additional carotenoid selected from among a group consisting of phytoene and phytofluene wherein the ratio between the lycopene and additional carotenoid is in the range of 20:1 to 5:1, preferably 8:1 to 5:1. Optionally, the composition may further contain vitamin E wherein the ratio between the lycopene and the vitamin E is in the range of 10:1 to 2:1, preferably 8:1 to 3:1.
  • A particular embodiment of the present invention relates to solid and liquid oral dosage forms selected from among a group comprising of a capsule, gel-cap, pellet, soft gel capsule, tablet, or other liquid or solid oral dosage forms known in the art, which comprises a carotenoid composition which contains 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more additional carotenoid selected from among phytoene and/or phytofluene. Said oral dosage form may further comprise 1.5 mg to 8 mg of vitamin E. Preferably, said oral dosage form comprises 5 mg of natural lycopene, 0.5 mg phytoene, 0.45 mg phytofluene and 1.8 mg of vitamin E. Said dosage form may further contain a pharmaceutically acceptable adjuvant, excepient, carrier, filler, stabilizer or additive.
  • The present invention further relates to foodstuff or beverages which contains a carotenoid composition as described herein. The foodstuff or beverage contain 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among a group consisting of phytoene and phytofluene. Said food-stuff or beverage may further contain 1.5 mg to 8 mg of vitamin E. Preferably, said food-stuff or beverage comprises 4.1 mg of natural lycopene, 2.2 mg phytoene, 1.6 mg phytofluene and 3.8 mg of vitamin E.
  • The present invention presents the following advantages:
      • 1. The compositions do not contain pro-vitamin A carotenoids, which at certain elevated dosages may be a health hazard. Thus, the present invention is safer and does not have the health risks as compositions described in the prior art.
      • 2. The protection is provided via in-vivo activity. Thus, the protective composition cannot be washed away or depleted like topical protective compositions.
      • 3. The compositions of the present invention have been shown to have improved bioavailability compared to other sources of natural lycopene and in comparison to synthetic lycopene, and thus offer improved protection against uv light-induced skin damage.
      • 4. The composition may bring about tanning of the skin to a brown hue in subjects exposed to uv radiation without the damages associated with uv radiation. This has both health and aesthetic advantages.
    EXAMPLES Example 1 Preparation of Carotenoid Composition
  • The lycopene used throughout the Examples is natural lycopene by LycoRed®.
  • Formulation I: each capsule contains:
  • Lycopene 4.88 mg
  • Phytoene 0.48 mg
  • Phytofluene 0.44 mg
  • Vitamin E 1.81 mg
  • in soft gel capsules which are prepared according to standard procedures known to the skilled artisan.
  • Formulation II: each soft drink bottle contains
  • Lycopene 4.1 mg
  • Phytoene 2.2 mg
  • Phytofluene 1.6 mg
  • Vitamin E 3.8 mg
  • Formulation III
  • Lycopene 5.5 mg
  • Vitamin E 2.0 mg
  • Example 2 Comparative Example of Protection against Erythema
  • Three treatment groups consumed the following lycopene supplements for 12 weeks:
  • a) Group 1—Lyc-O-Mato® soft gel capsules1) (1 capsule twice a day)
  • b) Group 2—Lyc-O-Guard™ drink2) (250 ml bottle twice a day)
  • c) Group 3—Synthetic lycopene hard shell capsules3) (1 capsule twice a day)
  • 1) The carotenoid fraction is a tomato extract containing natural lycopene, phytoene, phytofluene and tocopherols. 2) The carotenoid fraction is a tomato extract similar to Lyc-O-Mato® which is further enriched with phytoene, phytofluene and tocopherols. 3) The carotenoid fraction contains synthetic lycopene and tocopherols.
  • The minimal erythema dose (MED), which is the minimal dose of uv radiation which produces a minimal erythema (reddening of the skin) after 24 hours was determined by exposing different small areas of skin to increasing doses of uv radiation. The testing of the effectiveness of the carotenoid supplementation was tested by exposing the subjects to 1.25 of the individual MED at 0, 4 and 12 weeks from the beginning of lycopene supplementation. The effect of the radiation on the reddening and pigmentation of the skin was measured by a Minolta chronometer. The “a” and “b” value of the chronometer correlate to the reddening and pigmentation of the skin, respectively. The erythema (reddening) was determined 24 hours after radiation of uv radiation, by subtracting the value of “a” before radiation from the value of “a” 24 hours after radiation. The value obtained is denoted by “Δa”. Larger values of Δa correlate with increased erythema of the skin. FIG. 1 clearly demonstrates the improved protective effect against uv induced erythema, Lyc-O-Mato and Lyc-O-Guard have over synthetic lycopene.
  • While embodiments of the invention have been described by way of illustration, it will be apparent that the invention may be carried out with many modifications, variations and adaptations, without departing from its spirit or exceeding the scope of the claims.

Claims (27)

1. A method for protecting skin against damages caused by ultra-violet (uv) radiation from the sun, comprising administering to a subject in need of protection an effective amount of a composition containing lycopene from a natural source and one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof.
2. A method according to claim 1 wherein said composition further contains vitamin E.
3. A method according to claim 1, wherein 1 mg to 10 mg of a carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof are administered.
4. A method according to claim 3 wherein said composition contains 1.5% to 2.5% vitamin E.
5. A method according to claim 3, wherein about 5 mg are administered.
6. A method according to claim 4, wherein about 5 mg are administered.
7. A method according to any of claims 1 to 6 wherein the carotenoid serum level of the subject reaches a level within the range of 0.3 to 1.5 μM.
8. A method according to claim 8 wherein carotenoid serum levels of the subject reaches a level of about 1.2 μM.
9. A method according to any one of claims 1 to 8 wherein administration is in the form of a capsule, gel-cap, pellet, soft gel capsule or tablet which contain the carotenoid compositions.
10. A method according to any one of claims 1 to 8 wherein administration is in the form of oral administration via foodstuff or beverages.
11. A method according to any one of claims 1 to 11 wherein administration begins 7 to 30 days before exposure to uv radiation.
12. A carotenoid composition comprising of 6% to 15% lycopene of a natural source and 0.3% to 1.5% of one or more carotenoid selected from among phytoene and phytofluene or mixtures thereof.
13. A composition according to claim 12 further containing 1.5% to 2.5% vitamin E.
14. A composition according to claim 12 which contains about 6% natural lycopene, 0.5% phytoene and 0.5% phytofluene.
15. A composition according to claim 13 which contains about 6% natural lycopene, 0.5% phytoene, 0.5% phytofluene and 2% vitamin E.
16. An oral dosage form comprising of 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among phytoene and/or phytofluene or mixtures thereof.
17. An oral dosage form according to claim 16 further comprising 1.5 mg to 8 mg of vitamin E.
18. An oral dosage form according to claim 17 comprising 5 mg of natural lycopene, 0.5 mg phytoene, 0.45 mg phytofluene and 1.8 mg of vitamin E.
19. An oral dosage form according to claim 16 further containing a pharmaceutically acceptable adjuvant, excepient, carrier, filler, stabilizer or additive.
20. Use of a composition as described in any of claims 12 to 15 in the preparation of a skin protecting composition.
21. Use of a composition as described in any of claims 12 to 15 as a skin-protecting agent.
22. A composition according to any of claims 12 to 15 for use in the protection of skin against damages caused by uv radiation.
23. Foodstuff and beverage containing a composition as described in any of claims 12 to 15.
24. Foodstuff or beverage comprising of 5 mg to 15 mg of natural lycopene and 0.5 mg to 3.5 mg of one or more carotenoid selected from among a group consisting of phytoene and phytofluene.
25. Foodstuff or beverage according to claim 24 further comprising 1.5 mg to 8 mg of vitamin E.
26. Foodstuff or beverage according to claim 25 comprising 4.1 mg of natural lycopene, 2.2 mg phytoene, 1.6 mg phytofluene and 3.8 mg of vitamin E.
27. A pharmaceutically acceptable oral dosage form containing a composition as described in any of claims 12 to 15.
US10/495,514 2001-11-14 2002-11-05 Carotenoid composition and method for protecting skin Abandoned US20050053559A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/406,762 US10420715B2 (en) 2001-11-14 2009-03-18 Carotenoid composition and method for protecting skin

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL146496 2001-11-14
IL14649601A IL146496A0 (en) 2001-11-14 2001-11-14 Carotenoid composition and method for protecting skin
PCT/IL2002/000875 WO2003041678A1 (en) 2001-11-14 2002-11-05 Carotenoid composition and method for protecting skin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/406,762 Continuation US10420715B2 (en) 2001-11-14 2009-03-18 Carotenoid composition and method for protecting skin

Publications (1)

Publication Number Publication Date
US20050053559A1 true US20050053559A1 (en) 2005-03-10

Family

ID=11075862

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/495,514 Abandoned US20050053559A1 (en) 2001-11-14 2002-11-05 Carotenoid composition and method for protecting skin
US12/406,762 Expired - Fee Related US10420715B2 (en) 2001-11-14 2009-03-18 Carotenoid composition and method for protecting skin

Family Applications After (1)

Application Number Title Priority Date Filing Date
US12/406,762 Expired - Fee Related US10420715B2 (en) 2001-11-14 2009-03-18 Carotenoid composition and method for protecting skin

Country Status (15)

Country Link
US (2) US20050053559A1 (en)
EP (1) EP1443897B1 (en)
JP (2) JP2005515179A (en)
KR (1) KR20050043788A (en)
CN (1) CN100391433C (en)
AU (1) AU2002363613B2 (en)
BR (1) BR0214197A (en)
CA (1) CA2467056C (en)
ES (1) ES2641737T3 (en)
IL (3) IL146496A0 (en)
NO (1) NO20041803L (en)
PL (1) PL209422B1 (en)
RU (1) RU2341252C2 (en)
WO (1) WO2003041678A1 (en)
ZA (1) ZA200403529B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080114074A1 (en) * 2001-01-23 2008-05-15 Lycored Natural Products Industries Ltd. Anti-atherosclerosis composition containing carotenoids and method for inhibiting ldl oxidation
US20080287508A1 (en) * 2007-05-18 2008-11-20 Intermune, Inc. Altering pharmacokinetics of pirfenidone therapy
KR101448317B1 (en) 2006-07-02 2014-10-07 아이.비.알.이즈레일리 바이오테크놀로지 리서치 엘티디. Carotenoid compositions useful for whitening skin
CN114786655A (en) * 2019-10-10 2022-07-22 乐康瑞德有限公司 Compositions and methods for inhibiting collagen loss

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1508325B1 (en) * 2003-08-21 2009-03-11 Nestec S.A. Natural lycopene concentrate and process for producing the same
DE10349983A1 (en) 2003-10-24 2005-05-25 Basf Ag Process for the preparation of phytofluene
US9579298B2 (en) 2004-12-02 2017-02-28 Piotr Chomczynski Antioxidant dietary supplement compositions and methods for maintaining healthy skin
FR2985064B1 (en) * 2011-12-23 2016-02-26 Oreal METHOD FOR DELIVERING COSMETIC ADVICE
JP6012415B2 (en) * 2012-11-09 2016-10-25 アサヒグループホールディングス株式会社 Drunkenness reducing agent
CN103536506A (en) * 2013-10-15 2014-01-29 倪生标 Sunscreen lotion
CN104188812A (en) * 2014-09-02 2014-12-10 青岛永通电梯工程有限公司 Physical sunscreen cream
CN104323936A (en) * 2014-09-30 2015-02-04 青岛康和食品有限公司 Sunblocking cream
CN108379563A (en) * 2018-05-14 2018-08-10 青岛琛蓝海洋生物工程有限公司 A kind of radiation protection composition and preparation method thereof
WO2020021546A1 (en) * 2018-07-23 2020-01-30 Lycored Ltd. Lycopene compositions and methods for protecting skin against ultraviolet radiation
GB202109087D0 (en) 2021-06-24 2021-08-11 Norwegian Univ Sci & Tech Ntnu Therapeutic methods and devices

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920834A (en) * 1970-07-10 1975-11-18 Hoffmann La Roche Light-screening compositions and method
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
US6110748A (en) * 1997-04-30 2000-08-29 Motorola, Inc. Optical storage medium for binding assays
US6132790A (en) * 1991-09-06 2000-10-17 Betatene Limited Carotenoid composition
US20020012714A1 (en) * 2000-05-12 2002-01-31 Olson Bengt Krister Combined marine and plant extract compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749758B1 (en) * 1996-06-12 1998-08-07 Oenobiol Sa Lab COMPOSITION WITH TANNING AND PHOTOPROCTOR ACTIVITY AND ITS AESTHETIC APPLICATIONS
IL118697A (en) * 1996-06-20 1999-12-31 Lycored Natural Prod Ind Ltd Industrial processing of tomatoes
ES2217495T3 (en) 1998-02-13 2004-11-01 Societe Des Produits Nestle S.A. TOAST WITH GARNISH.
IL126076A (en) * 1998-09-04 2005-05-17 Ibr Ltd Transparent composition comprising phytoene and phytofluene
IL141038A (en) * 2001-01-23 2006-10-05 Lycored Natural Prod Ind Ltd Use of carotenoids in the preparation of anti-hypertension agents
EP1476143A1 (en) 2002-02-15 2004-11-17 DSM IP Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
CN1720030A (en) 2002-12-06 2006-01-11 帝斯曼知识产权资产管理有限公司 The new purposes of lycopene
EP1938810B1 (en) 2005-09-30 2014-06-18 Fuji Chemical Industry Co., Ltd. Ameliorating agent for metabolic syndrome
CN101442995A (en) 2006-05-15 2009-05-27 帝斯曼知识产权资产管理有限公司 Novel actives against prostate carcinoma
IL184575A0 (en) 2007-07-12 2008-01-20 Lycored Ltd Synergistic combinations for treating hypertension
CN105193777B (en) 2009-01-19 2019-06-28 利科雷德有限公司 The synergistic combination of carotenoid and polyphenol
JP2010208972A (en) 2009-03-09 2010-09-24 Kao Corp Endothelin expression inhibitor
JP2013510095A (en) 2009-11-06 2013-03-21 アルコン リサーチ, リミテッド Nutritional supplements to reduce dry eye
PL2976070T3 (en) 2013-03-19 2021-12-27 Lycored Ltd. Anti-inflammatory synergistic combinations of astaxanthin with lycopene and carnosic acid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920834A (en) * 1970-07-10 1975-11-18 Hoffmann La Roche Light-screening compositions and method
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
US6132790A (en) * 1991-09-06 2000-10-17 Betatene Limited Carotenoid composition
US6110748A (en) * 1997-04-30 2000-08-29 Motorola, Inc. Optical storage medium for binding assays
US20020012714A1 (en) * 2000-05-12 2002-01-31 Olson Bengt Krister Combined marine and plant extract compositions

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080114074A1 (en) * 2001-01-23 2008-05-15 Lycored Natural Products Industries Ltd. Anti-atherosclerosis composition containing carotenoids and method for inhibiting ldl oxidation
US7786175B2 (en) 2001-01-23 2010-08-31 Lycored Natural Products Anti-atherosclerosis composition containing carotenoids and method for inhibiting LDL oxidation
KR101448317B1 (en) 2006-07-02 2014-10-07 아이.비.알.이즈레일리 바이오테크놀로지 리서치 엘티디. Carotenoid compositions useful for whitening skin
US20080287508A1 (en) * 2007-05-18 2008-11-20 Intermune, Inc. Altering pharmacokinetics of pirfenidone therapy
US20110136876A1 (en) * 2007-05-18 2011-06-09 Intermune, Inc. Altering Pharmacokinetics of Pirfenidone Therapy
CN114786655A (en) * 2019-10-10 2022-07-22 乐康瑞德有限公司 Compositions and methods for inhibiting collagen loss

Also Published As

Publication number Publication date
PL209422B1 (en) 2011-08-31
RU2004114283A (en) 2005-03-20
KR20050043788A (en) 2005-05-11
JP2012180363A (en) 2012-09-20
WO2003041678A1 (en) 2003-05-22
IL161704A (en) 2015-11-30
IL146496A0 (en) 2002-07-25
US20090176872A1 (en) 2009-07-09
RU2341252C2 (en) 2008-12-20
AU2002363613B2 (en) 2007-08-02
IL161704A0 (en) 2004-09-27
ES2641737T3 (en) 2017-11-13
US10420715B2 (en) 2019-09-24
CN100391433C (en) 2008-06-04
PL368855A1 (en) 2005-04-04
CA2467056C (en) 2014-11-04
CA2467056A1 (en) 2003-05-22
BR0214197A (en) 2004-08-31
NO20041803L (en) 2004-08-06
EP1443897B1 (en) 2017-07-12
JP2005515179A (en) 2005-05-26
JP6125760B2 (en) 2017-05-10
ZA200403529B (en) 2005-01-12
EP1443897A1 (en) 2004-08-11
CN1585629A (en) 2005-02-23

Similar Documents

Publication Publication Date Title
US10420715B2 (en) Carotenoid composition and method for protecting skin
US7588785B2 (en) Methods and kits for reducing cellular damage, inhibiting free radical production and scavenging free radicals
KR100539633B1 (en) Nutritional Supplement to Treat Macular Degeneration
AU2002363613A1 (en) Carotenoid composition and method for protecting skin
US20050249821A1 (en) Nutritional supplement for treatment of ocular diseases
US20040219239A1 (en) Nutritional supplement based on blackcurrent seed oil
KR20080045083A (en) Methods of supressing uv light-induced skin carcinogenesis
US20040259959A1 (en) Method and pharmaceutical preparation for reducing the activity of cells
US20080171032A1 (en) Dietary supplement composition and method of use for the treatment and prevention of oxidative stress
US5948823A (en) Irradiation protection method
EP0712630A2 (en) Oral composition for the prevention of sun allergies containing a carotenoid, a tocopherol, ascorbic acid and selenium
US20080014156A1 (en) Photoprotectant composition for preventing sunburn and sun damage to the skin
Smith Immunomodulation and Antioxidant Nutraceuticals
Afshar et al. Endogenous Antioxidant Photoprotection and Its Enhancement in Human Skin
EP2952104A1 (en) Composition and method for preventing damage of human cells by ionising radiation
Kornhauser et al. β-Carotene Protection Against Phototoxicity In Vivo
Kedia et al. Shivani oxivore with wealth of benefits”
AU2002348711A1 (en) Method and pharmaceutical preparations for reducing the activity of cells
IES68517B2 (en) Anti-oxidant formulations

Legal Events

Date Code Title Description
AS Assignment

Owner name: LYCORED NATURAL PRODUCTS INDUSTRIES LTD., ISRAEL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZELKHA, MORRIS;NIR, ZOHAR;SEDLOV, TANYA;REEL/FRAME:015699/0555

Effective date: 20040511

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION